References
- Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013;188:733-48. https://doi.org/10.1164/rccm.201308-1483ST
- American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165:277-304. https://doi.org/10.1164/ajrccm.165.2.ats01
- Corte TJ, Copley SJ, Desai SR, Zappala CJ, Hansell DM, Nicholson AG, et al. Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur Respir J 2012;39:661-8. https://doi.org/10.1183/09031936.00174910
- Nogee LM, Dunbar AE 3rd, Wert SE, Askin F, Hamvas A, Whitsett JA. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001;344:573-9. https://doi.org/10.1056/NEJM200102223440805
- Hodgson U, Laitinen T, Tukiainen P. Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax 2002;57:338-42. https://doi.org/10.1136/thorax.57.4.338
- Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, Loyd JE, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med 2011;364:1503-12. https://doi.org/10.1056/NEJMoa1013660
- Reddy TL, Tominaga M, Hansell DM, von der Thusen J, Rassl D, Parfrey H, et al. Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur Respir J 2012;40:377-85. https://doi.org/10.1183/09031936.00165111
- Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824. https://doi.org/10.1164/rccm.2009-040GL
- Tomassetti S, Wells AU, Costabel U, Cavazza A, Colby TV, Rossi G, et al. Bronchoscopic lung cryobiopsy increases diagnostic confidence in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2016;193:745-52. https://doi.org/10.1164/rccm.201504-0711OC
- Poletti V, Ravaglia C, Gurioli C, Piciucchi S, Dubini A, Cavazza A, et al. Invasive diagnostic techniques in idiopathic interstitial pneumonias. Respirology 2016;21:44-50. https://doi.org/10.1111/resp.12694
- Halkos ME, Gal AA, Kerendi F, Miller DL, Miller JI Jr. Role of thoracic surgeons in the diagnosis of idiopathic interstitial lung disease. Ann Thorac Surg 2005;79:2172-9. https://doi.org/10.1016/j.athoracsur.2004.06.103
Cited by
- Interstitial Lung Fibrosis Imaging Reporting and Data System: What Radiologist Wants to Know? vol.44, pp.5, 2019, https://doi.org/10.1097/rct.0000000000001075
- Can YKL-40 be used as a biomarker for interstitial lung disease? : A systematic review and meta-analysis vol.100, pp.17, 2021, https://doi.org/10.1097/md.0000000000025631
- Pharmacological treatment of idiopathic pulmonary fibrosis and fibrosing interstitial lung diseases: current trends and future directions vol.5, pp.1, 2021, https://doi.org/10.23838/pfm.2020.00205
- Current advances in the treatment of autoimmune-associated interstitial lung diseases vol.64, pp.4, 2019, https://doi.org/10.5124/jkma.2021.64.4.264
- Treatment of chronic fibrosing interstitial lung diseases vol.64, pp.4, 2021, https://doi.org/10.5124/jkma.2021.64.4.277
- Recent advances in the diagnosis and management of interstitial pneumonia with autoimmune features: the perspective of rheumatologists vol.36, pp.3, 2019, https://doi.org/10.3904/kjim.2020.443
- Integrative analysis of lung molecular signatures reveals key drivers of idiopathic pulmonary fibrosis vol.21, pp.1, 2019, https://doi.org/10.1186/s12890-021-01749-3